Sarepta therapeutics announces fourth quarter and full-year 2022 financial results and recent corporate developments

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2022.
SRPT Ratings Summary
SRPT Quant Ranking